Does ERYTHROPOIETIN Cause Off label use? 590 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 590 reports of Off label use have been filed in association with ERYTHROPOIETIN. This represents 7.4% of all adverse event reports for ERYTHROPOIETIN.
590
Reports of Off label use with ERYTHROPOIETIN
7.4%
of all ERYTHROPOIETIN reports
66
Deaths
130
Hospitalizations
How Dangerous Is Off label use From ERYTHROPOIETIN?
Of the 590 reports, 66 (11.2%) resulted in death, 130 (22.0%) required hospitalization, and 19 (3.2%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERYTHROPOIETIN. However, 590 reports have been filed with the FAERS database.
What Other Side Effects Does ERYTHROPOIETIN Cause?
Product storage error (1,286)
Death (871)
Circumstance or information capable of leading to medication error (592)
Haemoglobin decreased (443)
Drug ineffective (370)
Anaemia (367)
Intercepted product administration error (301)
Incorrect product storage (268)
Fatigue (266)
Drug dose omission (240)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which ERYTHROPOIETIN Alternatives Have Lower Off label use Risk?
ERYTHROPOIETIN vs ESCHERICHIA COLI
ERYTHROPOIETIN vs ESCITALOPRAM
ERYTHROPOIETIN vs ESCITALOPRAM OXALATE
ERYTHROPOIETIN vs ESKETAMINE
ERYTHROPOIETIN vs ESLICARBAZEPINE